Alcidion Develops Data Acquisition Technology for NEDA

Alcidion Group Limited (ASX:ALC) has developed a new technology in partnership with the National Echocardiography Database of Australia (NEDA). The technology extracts, normalises and amalgamates data from Echocardiography (“Echo”) studies performed around Australia into a single, centralized cloud hosted database server. NEDA is headed up by internationally renowned cardiologist, Professor David Playford and the CEO of the Pulmonary Hypertension Society Australia and New Zealand Inc, Associate Professor Geoff Strange.

“The NEDA study will be the largest study of heart function in the world. The NEDA study will obtain detailed information on heart function obtained using heart ultrasound (“echocardiography”) across Australia, to create a secure database matched against national mortality data. The NEDA study will improve our understanding of heart disease and the risks associated with it” commented Professor David Playford.